[Pathogenesis and novel therapies for chronic GVHD]

Area of Science:

• Hematology
• Immunology
• Transplantation Medicine

Background:

• Chronic graft-versus-host disease (GVHD) is a major long-term complication of allogeneic hematopoietic cell transplantation.
• Significant advancements in understanding GVHD pathogenesis and diagnostic criteria have occurred.
• Treatment paradigms are shifting away from broad immunosuppression towards targeted therapies.

Purpose of the Study:

• To review the pathogenesis of chronic GVHD.
• To discuss current and emerging treatment strategies for chronic GVHD.
• To highlight the move towards individualized therapy.

Main Methods:

• Review of current literature on chronic GVHD pathogenesis and treatment.
• Analysis of recent advancements in targeted therapies.
• Discussion of novel agents and drugs in development.

Main Results:

• Objective diagnostic and evaluation criteria for chronic GVHD have been established.
• Novel targeted therapies are being developed and approved.
• Understanding of GVHD biological pathways has increased.

Conclusions:

• Treatment for chronic GVHD is evolving towards individualized approaches.
• Targeted therapies aim to improve quality of life and survival.
• Minimizing steroid exposure is a key goal in modern chronic GVHD management.